Triple-negative breast cancer (TNBC), which lacks estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression, is one of the most aggressive types of BC and is characterized by rapid recurrence, early metastasis, and poor prognosis. The gene discussed is ESR1; the disease is triple-negative breast carcinoma.